Ilana L. B. C. Camargo

Prof. Ilana L. B. C. Camargo

University of São Paulo, São Carlos, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
Longzhu CuiLongzhu Cui
Longzhu Cui
TITaisuke Isii
Taisuke Isii
MFMinoru Fukuda
Minoru Fukuda
TOTomonori Ochiai
Tomonori Ochiai
HNHui Min Neoh
Hui Min Neoh
KHKeiichi Hiramatsu
Keiichi Hiramatsu
We have previously reported the establishment of a Staphylococcus aureus laboratory strain, 10*3d1, having reduced susceptibility to daptomycin and heterogeneous vancomycin-intermediate S. aureus (VISA) phenotype. The strain was generated in vitro by serial daptomycin selection (Camargo, I. L., H. M. Neoh, L. Cui, and K. Hiramatsu, Antimicrob. Agents Chemother. 52:4289-4299, 2008). Here we explored the genetic mechanism of resistance in the strain by whole-genome sequencing and by producing gene-replaced strains. By genome comparison between 10*3d1 and its parent methicillin-resistant Staphylococcus aureus (MRSA) strain N315ΔIP, we identified five nonsynonymous single nucleotide polymorphisms (SNPs). One of the five mutations was found in the rpoB gene encoding the RNA polymerase β subunit. The mutation at nucleotide position 1862 substituted the 621st alanine by glutamic acid. The replacement of the intact rpoB with the mutated rpoB , designated rpoB(A621E) , conferred N315ΔIP with the phenotypes of reduced susceptibility to daptomycin and hetero-VISA. The rpoB(A621E) -mediated resistance conversion was accompanied by a thickened cell wall and reduction of the cell surface negative charge. Being consistent with these phenotypic changes, microarray data showed that the expression of the dlt operon, which increases the cell surface positive charge, was enhanced in the rpoB(A621E) mutant. Other remarkable findings of microarray analysis of the rpoB(A621E) mutant included repression of metabolic pathways of purine, pyrimidine, arginine, the urea cycle, and the lac operon, enhancement of the biosynthetic pathway of vitamin B2, K1, and K2, and cell wall metabolism. Finally, mutations identified in rplV and rplC , encoding 50S ribosomal proteins L22 and L3, respectively, were found to be associated with the slow growth, but not with the phenotype of decreased susceptibility to vancomycin and daptomycin, of 10*3d1.

1 December 2008 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
Ilana L. B. C. CamargoIlana L. B. C. Camargo
Ilana L. B. C. Camargo
HNHui Min Neoh
Hui Min Neoh
Longzhu CuiLongzhu Cui
Longzhu Cui
KHKeiichi Hiramatsu
Keiichi Hiramatsu
In order to better understand the mechanism of daptomycin resistance, we generated a daptomycin-nonsusceptible derivative strain, strain 10*3d1 (MIC = 3.0 μg/ml), by in vitro exposure of methicillin-resistantStaphylococcus aureusstrain N315ΔIP (MIC = 0.5 μg/ml) to daptomycin. We also obtained a daptomycin-susceptible phenotypic revertant strain, strain 10*3d1-10 (MIC = 1.0 μg/ml), by passaging 10*3d1 in drug-free medium for 10 days. The resultant triple-isogenic strains were analyzed for their phenotypes and gene expression by microarray analysis. No significant differences in the membrane fluidities of 10*3d1 and 10*3d1-10 compared to the membrane fluidity of N315ΔIP were observed. Resistant strain 10*3d1 had the highest membrane potential, followed by strains 10*3d1-10 and N315ΔIP. The vancomycin and teicoplanin MICs also increased. Teichoic acid genes (tagA,tagG),mprFencoding lysyl-phosphatidylglycerol, andclsencoding cardiolipin synthase were downregulated in 10*3d1 and 10*3d1-10. ThevraFandvraGgenes, which encode ATP binding cassette transporter proteins, were upregulated in 10*3d1. ThevraSRtwo-component regulatory system was upregulated, and electron microscopy revealed that the cell wall of 10*3d1 was significantly thicker than that of the parental strain. Taken together, daptomycin exposure selected a daptomycin-nonsusceptible strain with a phenotype similar to that of heterogeneous vancomycin-intermediateS. aureusand a transcription profile that partially overlapped that of heterogeneous vancomycin-intermediateS. aureus.

1 November 2006 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
PDF file
Ilana L. B. C. CamargoIlana L. B. C. Camargo
Ilana L. B. C. Camargo
MGM.S. Gilmore
M.S. Gilmore
ADAna Lúcia Costa Darini
Ana Lúcia Costa Darini

28 February 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JSJulia A. Schwartzman
Julia A. Schwartzman
FLFrancois Lebreton
Francois Lebreton
RSRauf Salamzade
Rauf Salamzade
TSTerrance Shea
Terrance Shea
MMMelissa J. Martin
Melissa J. Martin
MGMichael Gilmore
Michael Gilmore
Enterococci are gut microbes of most land animals. Likely appearing first in the guts of arthropods as they moved onto land, they diversified over hundreds of millions of years adapting to evolving hosts and host diets. Over 60 enterococcal species are now known. Two species, Enterococcus faecalis and Enterococcus faecium, are common constituents of the human microbiome. They are also now leading causes of multidrug-resistant hospital-associated infection. The basis for host association of enterococcal species is unknown. To begin identifying traits that drive host association, we collected 886 enterococcal strains from widely diverse hosts, ecologies, and geographies. This identified 18 previously undescribed species expanding genus diversity by >25%. These species harbor diverse genes including toxins and systems for detoxification and resource acquisition. Enterococcus faecalis and E. faecium were isolated from diverse hosts highlighting their generalist properties. Most other species showed a more restricted distribution indicative of specialized host association. The expanded species diversity permitted the Enterococcus genus phylogeny to be viewed with unprecedented resolution, allowing features to be identified that distinguish its four deeply rooted clades, and the entry of genes associated with range expansion such as B-vitamin biosynthesis and flagellar motility to be mapped to the phylogeny. This work provides an unprecedentedly broad and deep view of the genus Enterococcus , including insights into its evolution, potential new threats to human health, and where substantial additional enterococcal diversity is likely to be found.

12 November 2020 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
LMLuciene Andrade Da Rocha Minarini
Luciene Andrade Da Rocha Minarini
LALeonardo Neves de Andrade
Leonardo Neves de Andrade
EGEliana De Gregorio
Eliana De Gregorio
FGFilipa Grosso
Filipa Grosso
TNThierry Naas
Thierry Naas
Ilana L. B. C. CamargoIlana L. B. C. Camargo
Ilana L. B. C. Camargo
Editorial: Antimicrobial Resistance as a Global Public Health Problem: How Can We Address It?

1 June 2018 in Microbial Drug Resistance
Verified
Journal Article
Closed access
ADAndrei Nicoli Dabul
Andrei Nicoli Dabul
JAJuliana Sposto Avaca-Crusca
Juliana Sposto Avaca-Crusca
DTDaria Van Tyne
Daria Van Tyne
MGMichael S. Gilmore
Michael S. Gilmore
Ilana L. B. C. CamargoIlana L. B. C. Camargo
Ilana L. B. C. Camargo
A tigecycline-susceptible (TGC-S) Sequence Type (ST) 5 clinical methicillin-resistant Staphylococcus aureus (MRSA) strain was cultured in escalating levels of tigecycline, yielding mutants eightfold more resistant. Their genomes were sequenced to identify genetic alterations, resulting in resistance. Alterations in rpsJ , commonly related to tigecycline resistance, were also investigated. Tigecycline resistance was mediated by loss-of-function mutations in the transcriptional repressor mepR , resulting in derepression of the efflux pump mepA . Increased levels of resistance were obtained by successive mutations in mepA itself. No alterations in RpsJ were observed in selected strains, but we observed a K57M substitution, previously correlated with resistance, among TGC-S clinical strains. Thus, the pathway to tigecycline resistance in CC5 MRSA in vitro appears to be derepression of mep operon as the result of mepR loss-of-function mutation, followed by alterations in MepA efflux pump. This shows that other evolutionary pathways, besides mutation of rpsJ , are available for evolving tigecycline resistance in CC5 MRSA.